Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPost-Acute & Facility CareFidelis Care Prior Auth & Coverage Update | OpenPa…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentFidelis CarePolicy N/A

    Authorization and Utilization Review — Facility, Post-Acute, Behavioral Health, and Select Outpatient Services

    Customize your policy alerts

    Sign up for all Fidelis Care policy alerts

    Know when Fidelis Care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization, utilization review, and service-specific authorization rules for Fidelis Care Medicaid (and related lines) providers in New York State, including inpatient, outpatient, behavioral health, SUD, transplant, and surgical services.

    Policy Summary
    PayerFidelis Care
    PolicyAuthorization and Utilization Review — Facility, Post-Acute, Behavioral Health, and Select Outpatient Services
    Policy CodePolicy N/A
    Change TypeTechnical/coding and authorization clarification (no material coverage change)
    Effective DateMay 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for inpatient admissions (except emergency stabilization) and for listed CPT/HCPCS/J-codes before billing.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Inpatientauthorization requirement
    28 daysOASAS SUD exemption
    14 daysOMH inpatient exemption
    Appendix I
    Appendix I codes
    90867-69TMS PA

    Coverage and Medical Necessity Criteria

    Exemptions and utilization review triggers

    Exemptions from prior authorization and concurrent review apply when ALL listed conditions are met for specific in‑state, in‑network licensed facilities:

    OASAS Inpatient SUD prior auth exemption: Inpatient SUD services provided in New York State by OASAS‑licensed, in‑network facilities are not subject to prior authorization and are not subject to concurrent utilization review for the first 28 days provided the facility: notifies Fidelis Care of the inpatient admission and initial treatment plan within two business days (using the OASAS Appendix A Notification Form and LOCADTR tool), performs daily clinical review of the patient, periodically consults with Fidelis Care starting on or just prior to day 14 to ensure LOCADTR use, and provides a written discharge plan prior to discharge.28 days

    Services may be subject to review after day 28 or on discharge; submit LOCADTR and Appendix A per policy.

    OMH inpatient mental health prior auth exemption (all ages) and concurrent review triggers: Inpatient mental health treatment provided by OMH‑licensed hospitals in New York State are not subject to prior authorization review; however, utilization review (including prior authorization and concurrent review) will be conducted only for individuals who meet NYS OMH Best Practice clinical criteria (current AOT order; AOT expired within 5 years; high utilization in the prior 12 months defined as 3+ psychiatric inpatient hospitalizations OR 4+ psychiatric ED visits OR 3+ medical inpatient hospitalizations; readmission to any mental health inpatient unit within 30 days of discharge) or for individuals whose length of stay exceeds 30 days (concurrent review from Day 31 onwards).30 days for concurrent review from Day 31

    Facility must notify Fidelis Care within two business days of admission.

    OMH under‑18 additional exemption: For members under age 18 admitted to in‑network OMH‑licensed hospitals, Fidelis Care will not conduct concurrent utilization review during the first 14 days of admission provided the facility: notifies Fidelis Care of the admission and initial treatment plan within two business days using the OMH Two‑Day Notification and Initial Treatment Plan form, performs daily clinical review, and participates in periodic consultation with Fidelis Care.14 days

    Out‑of‑network facilities remain subject to concurrent review throughout admission.

    Inpatient admission authorization

    Covered when ALL of the following are met:

    Inpatient admission authorization: All inpatient admissions require prior authorization except emergency room services or any emergent service required to provide stabilization; prior authorization is required for post‑stabilization services and for inpatient admissions following emergency room services. All facility admissions are reviewed for medical necessity.

    New fax number for Inpatient ER: 833‑663‑1602.

    Behavioral health outpatient authorization exceptions

    Covered when service is outpatient behavioral health except the following which require authorization:

    Psychological/Neuropsychological Testing: Authorization is required for psychological and neuropsychological testing codes: 96116, 96121, 96130, 96131, 96132, 96133, 96136, 96137, 96138, 96139, and 96146. All requests should be submitted on the Psychological/Neuropsychological testing request form.

    See testing request form guidance.

    Developmental Pediatric Testing: Authorization is required for developmental pediatric testing codes 96112 and 96113. CPT 96110 (developmental screening) does not require authorization (excluding CHP) but has specific reimbursement and billing requirements (see 96110 rules).

    96110 must be billed with diagnosis Z13.41 or Z13.42 and follow Bright Futures/AAP schedule.

    Partial Hospitalization Admission Criteria

    Partial hospitalization mental health treatment is subject to utilization review and covered only when ONE of the following OMH criteria is met:

    Partial Hospitalization OMH criteria: Member meets any of the following: current Assisted Outpatient Treatment (AOT) court order; an AOT order that expired within the past 5 years; high utilization in the prior 12 months evidenced by 3 or more psychiatric inpatient hospitalizations OR 4 or more psychiatric ED visits OR 3 or more medical inpatient hospitalizations; readmission to any mental health inpatient unit within 30 days of a prior discharge; OR length of stay exceeds 30 days (concurrent review from Day 31 onwards).as listed

    Per NYS OMH Best Practice Manual; out‑of‑network facilities are subject to concurrent review throughout admission.

    Intensive Outpatient Admission/Concurrent Review Criteria

    Intensive outpatient mental health treatment requires authorization beyond initial 7 days and is subject to review when ONE of the following OMH criteria is met:

    Intensive Outpatient OMH criteria: Member meets any of the following: current AOT court order; an AOT order that expired within the past 5 years; high utilization in the prior 12 months evidenced by 3 or more psychiatric inpatient hospitalizations OR 4 or more psychiatric ED visits OR 3 or more medical inpatient hospitalizations; readmission to any mental health inpatient unit within 30 days of discharge; OR length of stay exceeds 30 days (concurrent review from Day 31 onwards).as listed

    No prior authorization needed for first 7 service days; additional days require authorization.

    TMS Medical Necessity Criteria

    Transcranial Magnetic Stimulation (TMS) is covered with authorization when ALL of the following are met:

    TMS coverage criteria: Member is >18 years old; TMS is delivered using an FDA‑cleared device consistent with labeled indications; confirmed diagnosis of major depressive disorder (MDD); and documented failure to respond to multiple trials of medication and evidence‑based psychotherapy during the current depressive episode.age > 18 and documented treatment failures

    Authorization required for CPT codes 90867, 90868, 90869; submit requests to Behavioral Health authorization contacts.

    Developmental Screening Coverage

    Developmental screening (96110) is covered in the first three years of life with the following rules:

    Developmental screening rules: CPT 96110 is reimbursed in addition to an Evaluation & Management service in the first three years of life. ASD screening may be reimbursed up to two times beginning at 18 months; global developmental delay screening may be reimbursed up to once per year. Screening must follow the Bright Futures/AAP periodicity schedule and 96110 must be billed with diagnosis code Z13.41 or Z13.42.First three years: ASD up to 2 times; global delay up to 1x/year

    Excludes CHP for the no‑authorization rule for 96110; providers must score and document standardized tool data.

    Children's Respite / HCBS Criteria

    Children's HCBS and short‑term respite services coverage and limits:

    Children's Respite rules: Short‑term Planned and Crisis Respite must be delivered in‑person (telehealth/telephone delivery not allowed); annual limit without medical necessity is 14 days (1,344 15‑minute units) per calendar year; services beyond this limit require medical necessity documentation including an LPHA attestation and submission of the NYS DOH Children's HCBS Authorization and Care Manager Notification form prior to service to Fidelis Care.14 days / 1,344 15‑minute units

    Submit Plan of Care and notification before services to avoid claims disruption.

    DXA no-authorization exceptions

    DXA (77080/77081) is not subject to authorization when ALL of the following age/diagnosis conditions are met:

    DXA no-auth exceptions: Authorization is not required when billed for: a) women age >65 — one 77080 or 77081 every two years with diagnosis Z13.820; b) men age >70 — one 77080 or 77081 every two years with diagnosis Z13.820; c) women age 51–64 — one 77080 or 77081 every two years when accompanied by any of the policy's listed diagnosis codes; d) men age 51–69 — one 77080 or 77081 every two years when accompanied by any of the policy's listed diagnosis codes. All other ages/diagnoses require authorization.one per 2 years

    Requests for other age/diagnosis combinations require authorization.

    OB Ultrasound coverage

    OB ultrasound rules:

    OB ultrasound auth rules: The first four OB ultrasounds for a normal pregnancy may be performed without prior authorization; five or more OB ultrasounds for a normal pregnancy require authorization. OB ultrasounds for high‑risk pregnancy diagnoses listed in the policy do not require authorization.>4 ultrasounds requires authorization for normal pregnancy

    Normal pregnancy diagnosis examples: Z32.01, Z33.1, Z34.00‑Z34.03, etc.; high‑risk diagnosis list exempts authorization.

    Therapy services (PT/OT/ST)

    PT/OT/ST prior authorization requirements:

    Therapy PA rules: Effective 10/1/2021, home and outpatient physical therapy (PT), occupational therapy (OT), and speech therapy (ST) performed by a therapy provider after the initial evaluation require prior authorization through Evolent (NIA). Home therapy requires authorization for the initial evaluation. This program excludes PT/OT/ST provided in inpatient settings, ER, SNF/sub‑acute rehab, or during an observation stay. CPT codes 92610 and 92611 do not require prior authorization.N/A

    If billing codes other than initial evaluation CPT codes are used, an authorization request must be sent to Evolent within 1 business day (outpatient) or 2 business days (home health), or to Fidelis for inpatient settings.

    Not covered for Low Back Pain

    Services not covered for members with a diagnosis of Low Back Pain:

    Low back pain exclusions: The following are not covered when billed with a diagnosis of Low Back Pain: prolotherapy; therapeutic facet joint steroid injections in the lumbar and sacral regions (with or without CT fluoroscopic guidance); therapeutic injections of steroids into intervertebral discs; and continuous or intermittent traction.N/A

    These services are listed as not covered for Low Back Pain diagnoses.

    Out-of-state or out-of-network providers must request prior authorization for outpatient substance use services that in‑network, in‑state OASAS‑licensed providers do not require authorization for. This includes outpatient office visits, therapy or counseling visits, outpatient clinic visits for substance use disorder treatment, intensive outpatient treatment programs, outpatient rehabilitation, and opioid treatment programs; providers located outside New York State or outside Fidelis Care’s network remain subject to authorization and concurrent review requirements.

    Certain CLHRS/OLHRS services delivered by designated 29‑I facilities are excluded from Utilization Review; Fidelis Care will not conduct UR on the OLHRS items listed for services delivered by 29‑I facilities. However, when a 29‑I facility provides Children and Family Treatment & Support Services (CFTSS) or Children's Home and Community Based Services (Children's HCBS), those services remain subject to the authorization requirements specified in their respective sections and workflow (e.g., Children's HCBS authorization and notification forms).

    The policy lists explicit exclusions and code‑based non‑coverage: HCPCS codes for medications that are not FDA‑approved (for example, J1726) are a benefit exclusion and will be denied when billed. In addition, specific service/code combinations are non‑covered per Appendix and Pharmacy guidance (see Appendix I). Therapeutic service exclusions for certain diagnoses (see Low Back Pain exclusions) are described elsewhere in the policy.

    CPT code 20610 (injection, small joint) is designated as non‑covered when billed in combination with hyaluronic acid products listed (e.g., J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332) and an osteoarthritis of the knee diagnosis (specified M17 series codes). Claims with this billing combination will be denied as non‑covered.

    For routine (normal) pregnancies, the first 4 OB ultrasounds may be performed without prior authorization. When a member receives five or more OB ultrasounds for a normal pregnancy (diagnosis codes such as Z32.01, Z33.1, Z34.00‑Z34.03, etc.), authorization is required for the fifth and subsequent ultrasounds; OB ultrasounds for high‑risk pregnancy diagnoses listed in the policy do not require authorization.

    The policy explicitly lists therapeutic procedures that are not covered for members with a diagnosis of Low Back Pain. These include: prolotherapy; therapeutic facet joint steroid injections in the lumbar and sacral regions (with or without CT fluoroscopic guidance); therapeutic steroid injections into intervertebral discs; and continuous or intermittent traction. Claims for these services when billed with a Low Back Pain diagnosis will be denied as not covered.

    Code Tables and Billing Codes

    Transplant-related CPT codes (partial list)CPTCovered
    32850listed transplant-related code
    32851listed transplant-related code
    32852listed transplant-related code
    32853listed transplant-related code
    Behavioral health testing codes - covered CPT/HCPCSCPTCovered
    96116Psychological testing
    96121Psychological testing
    96130Neuropsychological testing
    96131Neuropsychological testing
    96132-96139Psychological/Neuropsychological testing series
    96146Psych testing admin scoring
    96112Developmental testing
    96113Developmental testing
    96110Developmental screening
    Psychological/Neuropsychological testing - covered codesCPTCovered
    96116Psychological testing
    96121Psychological testing
    96130Neuropsychological testing
    96131Neuropsychological testing
    96132Neuropsychological testing
    96133Neuropsychological testing
    96136Psychological testing
    96137Psychological testing
    96138Psychological testing
    96139Psychological testing
    1–10 of 11
    1/2
    Developmental Pediatric Testing / Screening - covered codesCPTCovered
    96112Developmental testing
    96113Developmental testing
    96110Developmental screening
    Partial Hospitalization / Intensive Outpatient - covered codesHCPCS|CPTCovered
    H0035Partial hospitalization services
    S9484Partial hospitalization or crisis intervention
    H2013Intensive outpatient services
    90899Unlisted psychiatric service/procedure
    S9480Intensive outpatient service
    Behavioral Health program codes (ACT, PROS, CORE, CFTSS) - covered codesHCPCS|CPTCovered
    H0040Assertive Community Treatment (ACT)
    H2012Continuing Day Treatment / IPRT referenced
    H2012KIntensive Psychiatric Rehabilitation Treatment (IPRT)
    H2017Psychosocial Rehabilitation (CORE)
    H0036Community Psychiatric Support and Treatment (CPST)
    H0038Peer Supports / Youth Peer Supports and Family Peer Support Services
    H2001Crisis Intervention
    H0004Other Licensed Practitioner service
    H2011Other Licensed Practitioner service
    HCBS and CLHRS service codes - covered codesHCPCSCovered
    T2017Habilitation and Residential Support Services
    T2015Pre-Vocational Services
    T2019Transitional Employment
    H2023Supported Employment
    T2013Education Support Services
    A0160Provider Travel Supplement
    Home Health Care / Consumer Directed codes - covered codesHCPCSCovered
    T1001Nursing Assessment
    S5130U1Personal Care Level I (housekeeping)
    T1019U1Personal Care Level II per 15 mins
    T1019U3Level II Mutual Case (multiple)
    T1019U2Level II Shared Aide (up to two)
    T1019U4Level II - Hard to Serve
    T1020Live In Level II per diem
    G0162Nursing Supervision
    T1019U6Consumer Direct 1 Client
    T1019U7Consumer Direct 2 Client
    1–10 of 14
    1/2
    Selected diagnostic procedure codes - covered examplesCPTCovered
    91110Wireless Capsule Endoscopy
    91111Wireless Capsule Endoscopy
    91112Wireless Motility Capsule
    91113Wireless Motility Capsule
    Consumer Directed service HCPCS - covered HCPCS groupHCPCSCovered
    T1019U6Consumer Direct 1 Client
    T1019U7Consumer Direct 2 Client
    T1019U8Consumer Direct 1 Client Enhanced
    T1019U9Consumer Direct 2 Client Enhanced
    T1020U6Consumer Direct Live In 1 Client
    T1020U7Consumer Direct Live In 2 Client
    OB ultrasound relevant diagnosis codes (examples)ICD-10
    Z32.01Encounter for pregnancy test and childbirth planning
    Z33.1Pregnant state
    Z34.00-Z34.03Encounter for supervision of normal first pregnancy
    DXA and TBS scans - codes and coverage statusCPTCovered
    77080DXA scan
    77081DXA scan
    77089TBS scan
    77090TBS scan
    77091TBS scan
    77092TBS scan
    Therapeutic and monitoring CPT codes - covered listCPTCovered
    96567Phototherapy
    96573Phototherapy
    96574Phototherapy
    96900Phototherapy
    96910Phototherapy
    96912Phototherapy
    96913Phototherapy
    96920Phototherapy
    96921Phototherapy
    96922Phototherapy
    1–10 of 11
    1/2
    Pain management codes (partial list) - coveredCPTCovered
    20526Trigger point injection
    20550Injection procedure
    20551Injection procedure
    DME and procedural codes for erectile dysfunction - coveredCPT | HCPCSCovered
    37788Erectile dysfunction device/procedure
    37790Erectile dysfunction device/procedure
    54400Penile surgery
    L7900Penile prosthesis
    Appendix I — HCPCS C/G codes requiring prior authorizationHCPCSCovered
    C9047caplacizumab-yhdp (Cablivi) and J-code mappings
    C9145aprepitant aponvie inj and mappings
    C9166secukinumab, intravenous and mappings
    C9301obecabtagene autoleucel and mappings
    C9399unclassified drugs/biologics
    G0516insertion of implant
    G0517removal of implant
    Appendix I mappings (sample grouped entries)mixed
    C9047series entry mapping (e.g., caplacizumab-yhdp / J0256 / alpha 1-prot inhib NOS / J0609 / ferric citrate, oral, ESRD on)
    C9145series entry mapping (e.g., aprepitant aponvie inj / J0257 / alpha 1-prot inhib (Glassia) / Dialysis)
    C9166series entry mapping (e.g., secukinumab, intravenous / J0270 / alprostadil (Prostin VR) / J0615 / calcium acetate, oral, ESRD on)
    Appendix I mappings (continued)mixed
    C9301obecabtagene autoleucel / J0402 / aripiprazole (Abilify asimtufii) / J0691 / lefamulin (Xenleta)
    C9302zanidatamab-hrii inj (Ziihera) / J0491 / anifrolumab-fnia / J0706 / caffeine citrate inj
    Appendix I long list of J-codes and mappings — extended code groupsmixed
    J0129abatacept (Orencia) / various alternate mappings
    J0139adalimumab (Humira) / various alternate mappings
    J0218olipudase alfa-rpcp (Xenpozyme) / J0603 / sevelamer carbonate, oral, ESRD on Dialysis (Renagel) / J1072 / testosterone cypionate inj (Azmiro)
    J1290ecallantide (Kalbitor) / J1599 / immune globulin / J2503
    J3399onasemnogene abeparvovec (Zolgensma) / J7205 and related mappings
    J7165prothrombin complex concentrate (human-lans) / J7214 and related mappings
    J7181factor XIII A-subunit recombinant (Tretten) / J7320 / hyaluronan (Durolane, Genvisc) / J7999 / J8499 / J8510
    Prior authorization required drug administration codes (partial)HCPCSCovered
    J7170listed drug/admin codes mapping (see Appendix I)
    J7175listed drug/admin codes mapping (see Appendix I)
    J7179listed drug/admin codes mapping (see Appendix I)
    J7181listed drug/admin codes mapping (see Appendix I)
    J7182listed drug/admin codes mapping (see Appendix I)
    Prior authorization required drug administration codes (partial)HCPCSCovered
    J7183listed drug/admin codes mapping (see Appendix I)
    J7185listed drug/admin codes mapping (see Appendix I)
    J7186listed drug/admin codes mapping (see Appendix I)
    J7189listed drug/admin codes mapping (see Appendix I)
    J7190listed drug/admin codes mapping (see Appendix I)
    Prior authorization required drug administration codes (partial)HCPCSCovered
    J7192listed drug/admin codes mapping (see Appendix I)
    J7193listed drug/admin codes mapping (see Appendix I)
    J7194listed drug/admin codes mapping (see Appendix I)
    J7195listed drug/admin codes mapping (see Appendix I)
    J7196listed drug/admin codes mapping (see Appendix I)
    Prior authorization required drug administration codes (partial)HCPCSCovered
    J7197listed drug/admin codes mapping (see Appendix I)
    J7198listed drug/admin codes mapping (see Appendix I)
    J7199listed drug/admin codes mapping (see Appendix I)
    J7200listed drug/admin codes mapping (see Appendix I)
    J7201listed drug/admin codes mapping (see Appendix I)
    Prior authorization required drug administration codes (partial)HCPCSCovered
    J7202listed drug/admin codes mapping (see Appendix I)
    J7203listed drug/admin codes mapping (see Appendix I)
    J7204listed drug/admin codes mapping (see Appendix I)
    Prior authorization required chemotherapy/drug admin codes (partial)HCPCSCovered
    J9048bortezomib (Fresnius Kabi) and related mappings
    J9049bortezomib (Hospira) and related mappings
    J9051bortezomib inj (Maia) and related mappings
    J9052carmustine (Accord) and related mappings
    Prior authorization required chemotherapy/drug admin codes (partial)HCPCSCovered
    J9054bortezomib inj (Boruzu) and related mappings
    J9056bendamustine (Vivimusta) and related mappings
    J9057copanlisib (Aliqopa) and related mappings
    J9058bendamustine (Baxter) and related mappings
    Prior authorization required biologic/oncology codes (partial)HCPCSCovered
    J9118calaspargase pegol-mknl (Asparlas) and mapping Q5103/Q5104
    J9120dactinomycin (Cosmegan) and mapping J9316/Q5109
    J9144daratumumab and related mappings
    J9145daratumumab (Darzalex) and related mappings
    Prior authorization required biologic/oncology codes (partial)HCPCSCovered
    J9161denileukin diftitox and related mappings
    J9173durvalumab (Imfinzi) and related mappings
    J9176elotuzumab (Empliciti) and related mappings
    J9177enfortumab (Padcev) and related mappings
    Prior authorization required oncology/biologic codes (partial)HCPCSCovered
    J9198gemcitabine (Infugem) and related mappings
    J9203gemtuzumab (Mylotarg) and related mappings
    J9204mogamulizumab (Poteligeo) and related mappings
    J9210emapalumab (Gamifant) and related mappings
    Prior authorization required oncology/biologic codes (examples)HCPCSCovered
    J9216emapalumab/interferon gamma mappings and related Q-codes
    J9223histrelin implant and isatuximab mappings
    J9227ipilimumab (Yervoy) and inotuzumab mappings
    J9228ipilimumab/inotuzumab and related mappings
    J9229melphalan hydrochloride and related mappings
    J9245melphalan hydrochloride and related mappings
    J-code groups (examples)mixedCovered
    J9204mapped multiple product identifiers (see appendix)
    J9210mapped multiple product identifiers (see appendix)
    J9216mapped multiple product identifiers (see appendix)
    Additional J-code groupsmixedCovered
    J9223listed with associated biologic products
    J9225listed with associated biologic products
    J9227listed with associated biologic products
    J9228listed with associated biologic products
    J9229listed with associated biologic products
    Further J-code groupsmixedCovered
    J9245listed with product mappings
    J9246listed with product mappings
    J9248listed with product mappings
    J9249listed with product mappings
    J9255listed with product mappings
    J9258listed with product mappings
    J9259listed with product mappings
    J9261listed with product mappings
    Q-code groupsmixedCovered
    Q5144Q-code with multiple sub-mappings
    Q5145Q-code with multiple sub-mappings
    Q5146Q-code with multiple sub-mappings
    Q5147Q-code with multiple sub-mappings
    Q5148Q-code with multiple sub-mappings
    Q5149Q-code with multiple sub-mappings
    Q5150Q-code with multiple sub-mappings
    Q5151Q-code with multiple sub-mappings
    Q5152Q-code with multiple sub-mappings
    Q999x groupsmixedCovered
    Q9991Q9991 mappings (buprenorphine ER etc.)
    Q9992Q9992 mappings (buprenorphine ER etc.)
    Q9996Q9996 mappings (ustekinumab SubQ etc.)
    Q9997Q9997 mappings (ustekinumab IV etc.)
    Q9998Q9998 mappings (ustekinumab inj etc.)
    Q9999Q9999 mappings (ustekinumab-aauz etc.)
    S-code groupsmixedCovered
    S0012S0012 mappings (butorphanol nasal, peg interferon alfa-2A, etc.)
    S0017S0017 mappings (aminocaproic acid inj, pegylated interferon alfa-2B, etc.)
    S0021S0021 mappings (cefoperazone inj, dilutant for epoprostenol, dispensing services, etc.)
    S0034S0034 mappings (ofloxacin inj, exemestane oral, etc.)
    S0040S0040 mappings (ticarcillin inj, becaplermin gel, etc.)
    S0074S0074 mappings (cefotetan inj, dextroamphetamine oral, etc.)
    S0078S0078 mappings (fosphenytoin inj, calcitriol oral, etc.)
    Developmental screening frequency (First Three Years) — 96110 reimbursement rules

    Prior Authorization, Documentation, and Routing Instructions

    Prior Authorization

    Prior Authorization Required for Listed Services

    Prior authorization is required for the services and codes listed below. Failure to obtain required prior authorization may result in claim denial or retrospective review. When prior authorization is required, submit requests to the delegated vendor when indicated (Evolent/TurningPoint/other) or to Fidelis Care per the routing instructions in each callout.

    • All inpatient admissions require authorization except emergency room stabilization services; post-stabilization inpatient care requires authorization.
    • Outpatient surgical procedures enumerated in Sections II–III require prior authorization (see code lists and delegated vendors).
    • Certain orthopedic/spinal, ENT, and cardiac surgical procedure prior authorizations have been delegated to Evolent (NIA) or TurningPoint — follow delegated routing for those CPTs.
    Prior Authorization

    Psychological/Neuropsychological Testing — Authorization Submission Requirements

    Psychological and neuropsychological testing codes require authorization. All requests must be submitted using the Fidelis Psychological/Neuropsychological Testing request form and include clinical documentation supporting test selection and indications.

    Admission Criteria by Setting

    acute/sub-acute/SNF admission criteria

    Acute/sub‑acute/SNF admission: Authorization required for all inpatient admissions except emergency stabilization; medical rehabilitation (acute, sub‑acute, skilled nursing rehabilitation) requires prior authorization; all facility admissions are reviewed for medical necessity.

    Fax for inpatient ER: 833‑663‑1602.

    Inpatient SUD admission criteria

    Inpatient SUD admission: In‑network, in‑state OASAS‑licensed inpatient SUD facilities are not subject to prior authorization and are exempt from concurrent utilization review for the first 28 days if the facility notifies Fidelis Care of admission and initial treatment plan within two business days, performs daily clinical review, periodically consults with Fidelis Care starting on or just prior to day 14, and provides a written discharge plan prior to discharge.28 days

    Out‑of‑state or out‑of‑network facilities must request prior authorization and are subject to concurrent review throughout admission.

    Continued Stay / Ongoing Care Criteria

    inpatient continued stay criteria

    Inpatient continued stay triggers: Inpatient SUD may be subject to utilization review after the 28th day or upon discharge; OMH inpatient mental health admissions meeting listed triggers (AOT orders, recent AOT, high utilization, 30‑day readmission) or length of stay exceeding 30 days will be subject to utilization/concurrent review as specified.28 days; Day 31

    Facilities must consult with Fidelis Care per SUD and OMH rules.

    partial hospitalization / intensive outpatient continued stay criteria

    Partial hospitalization / IOP continued stay: Concurrent review is required for partial hospitalization and intensive outpatient services when members do not meet OMH triggers or when length of stay exceeds 30 days (concurrent review from Day 31 onward). Intensive Outpatient has an initial 7‑day period without prior authorization; additional days require authorization and are subject to concurrent review triggers.Day 31; after first 7 days for IOP

    Discharge Planning and Criteria

    For in‑network, New York State OASAS‑licensed inpatient SUD facilities, the policy requires notification and documentation but does not define additional top‑level discharge criteria as standalone nodes. Facilities must notify Fidelis Care of the admission and initial treatment plan within two business days, perform daily clinical review, periodically consult with Fidelis Care (beginning on or just prior to day 14), and provide a written discharge plan to the member and Fidelis Care prior to discharge indicating whether services in the discharge plan are secured or reasonably available. Inpatient SUD services may be subject to utilization review after day 28 or upon discharge using the LOCADTR clinical review tool.

    Children's HCBS and related short‑term Planned and Crisis Respite do not present separate top‑level discharge criteria in the policy inventory. The policy requires submission of the NYS Children's HCBS Authorization and Care Manager Notification Form and any LPHA attestation to support services beyond the annual limits; providers must submit required documentation prior to rendering services to avoid claim processing disruptions and should submit Plan of Care items as specified.

    Other discharge items in the facility care sections do not identify additional top‑level discharge criteria in the inventory. Relevant discharge expectations include those for home health/consumer‑directed services and hospice: providers must ensure discharge planning and documentation are completed per the applicable benefit rules (for example, hospice requests for Medicaid members should be submitted to Fidelis Care).

    Initial Days and Service Day Limits

    inpatient SUD and inpatient mental health — initial concurrent review exemption windows
    OASAS inpatient SUD exemptionIn-network, in-state OASAS‑licensed inpatient SUD services are not subject to concurrent utilization review for the first 28 days provided the facility notifies Fidelis Care of admission and initial treatment plan within 2 business days, performs daily clinical review, consults with Fidelis Care near day 14, and submits LOCADTR documentation.
    OMH under‑18 exemptionIn‑network OMH‑licensed inpatient mental health admissions for members <18 are not subject to concurrent utilization review for the first 14 days if the facility notifies Fidelis Care within 2 business days using the OMH Two‑Day Notification and Initial Treatment Plan form, performs daily clinical review, and participates in periodic consultation.
    Post‑exemption reviewInpatient SUD services may be subject to utilization review after day 28 or upon discharge; OMH stays meeting triggers or exceeding thresholds may be reviewed per policy.
    intensive outpatient / continuing day treatment — initial service days
    Initial no‑PA window

    Background and Scope

    This update restates delegated authorization arrangements and clarifies utilization review during the COVID‑19 era. Key delegation and restatement points include: OASAS‑licensed in‑network inpatient SUD services in New York State are exempt from prior authorization and from concurrent utilization review for the first 28 days when the facility meets notification and documentation requirements (notify within two business days, perform daily clinical review, consult with Fidelis Care near day 14, and provide a written discharge plan prior to discharge). Similarly, OMH‑licensed inpatient mental health facilities have defined notification and documentation workflows to avoid concurrent review for the first 14 days for members under 18. The policy also reiterates that certain prior authorization responsibilities and radiology authorization processes have been delegated (for example, radiology prior authorization delegated to Evolent/NIA) and that providers should follow the specified notification and auth submission procedures.

    Definitions and Tools

    LOCADTR Medical Necessity Tool — definition / reference
    DefinitionLOCADTR Medical Necessity Tool: a standardized clinical review tool used for SUD inpatient clinical review and utilization determination by facilities and Fidelis Care.
    Use timingFacilities must use LOCADTR for periodic consultation starting on or just prior to day 14 of inpatient SUD treatment and may submit LOCADTR modules for review.
    SubmissionOASAS Appendix A Notification Form and LOCADTR tool may be faxed to 833-663-1608 or emailed to LOCADTR@fideliscare.org per instructions.
    OMH notification form — Two‑Day Notification and Initial Treatment Plan form reference
    Form nameOMH Two‑Day Notification and Initial Treatment Plan form (used to notify Fidelis Care within two business days to avoid concurrent review for under‑18 admissions).
    Submission methods

    Coding Notes, Frequency, and Limits

    Prior Authorization

    Ensure PA is obtained for listed services and codes before billing

    Prior authorization is required for the services and codes listed in the policy; providers must follow the policy's routing and submission instructions to obtain PA prior to service or billing.

    • All inpatient admissions require authorization (emergent stabilization excluded).
    • Appendix I and sections II–V list numerous CPT/HCPCS/J/Q/S codes that require PA.
    Developmental screening and imaging — coding/frequency key values
    CodesOB ultrasound: first 4 ultrasounds without authorization for normal pregnancy; DXA: CPT 77080 and 77081 with two‑year frequency exceptions as specified.
    OB auth threshold>4 OB ultrasounds for a normal pregnancy require authorization (diagnosis examples: Z32.01, Z33.1, Z34.00‑Z34.03).
    DXA frequency

    Policy Revision History

    2024-01-01delegation_update

    Musculoskeletal Management Program delegation to Evolent (NIA) for orthopedic and spinal procedure authorization and device review became effective.

    Policy Summary
    PayerFidelis Care
    PolicyAuthorization and Utilization Review — Facility, Post-Acute, Behavioral Health, and Select Outpatient Services
    Policy CodePolicy N/A
    Change TypeTechnical/coding and authorization clarification (no material coverage change)
    Effective DateMay 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for inpatient admissions (except emergency stabilization) and for listed CPT/HCPCS/J-codes before billing.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaCode Tables and Billing CodesPrior Authorization, Documentation, and Routing InstructionsAdmission Criteria by SettingContinued Stay / Ongoing Care CriteriaDischarge Planning and CriteriaInitial Days and Service Day LimitsBackground and ScopeDefinitions and ToolsCoding Notes, Frequency, and LimitsPolicy Revision History
    Policy ruleCPT 96110 reimbursed in addition to E&M during the child's first three years of life; ASD screening may be reimbursed up to 2 times starting at 18 months; global developmental delay screening may be reimbursed up to once per year.
    Billing diagnosis requirement96110 must be billed with diagnosis code Z13.41 (autism screen) OR Z13.42 (screening for global developmental delays).
    Authorization statusNo prior authorization required for 96110 (excludes Child Health Plus).
    Short-term Planned and Crisis Respite annual limit
    Annual limitShort-term Planned and Crisis Respite may not exceed 14 days per calendar year (equivalent to 1,344 15‑minute units) without medical necessity.
    Beyond-limit requirementRespite beyond the annual limit requires medical necessity documentation, including an LPHA attestation and NYS DOH Children's HCBS Authorization and Care Manager Notification form submitted to Fidelis Care.
    Submission timingNotification and authorization form should be submitted prior to rendering service to prevent claim disruptions.
    OB ultrasound allowance without authorization
    Routine pregnancy allowanceThe first 4 OB ultrasounds for a normal pregnancy may be performed without authorization.
    Exceeding allowanceFive or more ultrasounds for a normal pregnancy (diagnosis codes Z32.01, Z33.1, Z34.00-Z34.03, etc.) require prior authorization.
    High-risk pregnanciesOB ultrasounds for listed high-risk pregnancy diagnoses (O09.xx, O36.80Xx, etc.) do not require authorization.
    DXA frequency — 77080/77081
    Frequency allowanceOne DXA (CPT 77080 or 77081) is allowed every two years for specified age/diagnosis groups.
    Age/diagnosis exceptionsWomen >65 and men >70: one 77080/77081 every two years when billed with diagnosis Z13.820; Women 51–64 and men 51–69: one 77080/77081 every two years when accompanied by specified diagnosis codes on the attached list.
    Authorization requiredRequests for 77080/77081 for other age groups or diagnoses require prior authorization.
    DSMT units — Diabetes Self-Management Training
    Allowed amountMembers are allowed 10 hours (20 units) of DSMT in a continuous 6‑month period.
    Billing codesDSMT services are covered when billed with G0108 and G0109.
    Authorization statusThese DSMT services no longer require prior authorization but must be provided by certified providers.
    • Affected CPTs include: 96116, 96121, 96130-96131, 96132-96133, 96136-96139, 96146.
    • Attach completed test request form and relevant clinical notes/diagnoses.
    • Use delegated routing only if stated elsewhere; otherwise submit to Fidelis per testing form instructions.
    Prior Authorization

    Developmental Pediatric Testing — Authorization Rules and Documentation

    Developmental pediatric testing and screening have specific authorization rules. Code 96112 and 96113 require authorization. CPT 96110 (developmental screening) does not require authorization (except for CHP) but must be billed with the appropriate screening diagnosis and documented per guidance.

    • 96112, 96113 — Authorization required.
    • 96110 — No authorization required (excluding Child Health Plus). When billed, use diagnosis Z13.41 (autism screen) OR Z13.42 (screening for global developmental delays) and document use of a standardized validated screening tool, scoring, and recommendations.
    • Developmental screening frequency: follow Bright Futures/AAP periodicity — ASD screening up to twice in first three years (beginning at 18 months); global developmental delay screening up to once per year in first three years.
    Prior Authorization

    TMS Prior Authorization — CPTs 90867-90869

    Transcranial Magnetic Stimulation (TMS) is a covered service but requires prior authorization for the listed CPT codes and medical necessity criteria must be met.

    • Authorization required for CPT 90867, 90868, 90869.
    • Requests may be submitted via email to qhcmbh@fideliscare.org, fax 833-561-0098, or by calling 1-888-FIDELIS and following Behavioral Health prompts (ext. 16072).
    • Members must be >18, have FDA-cleared device used per labeled indications, a confirmed diagnosis of major depressive disorder, and failure of appropriate medication and evidence-based psychotherapy trials during the current episode.
    Prior Authorization

    DME Prior Authorization — DME/Supplies Routing and MLTC Specifics

    Durable medical equipment (DME) and certain supply codes require prior authorization; refer to NYS DME Manual and program-specific routing. MLTC-specific supply codes also require authorization.

    • DME coverage and benefit limits follow the Medicaid DME Program Manual: https://www.emedny.org/ProviderManuals/DME/index.aspx.
    • Effective 4/1/23 select DME supplies billed by physicians (POS 12/14) were transitioned to NYS Fee-for-Service (NYRx); check the Medical Supply Procedure Codes list for those supplies.
    • For MLTC members, the following supply HCPCS require authorization: A4335, A4554, T4521-T4524, T4529, T4530, T4533, T4535, T4537, T4539, T4540, T4543.
    • Personal Emergency Response Systems (PERS) and Consumer Directed Personal Assistance Services (CDPAS) require authorization.
    • Submit DME authorization requests per Fidelis routing unless otherwise directed in the DME manual or member line of business guidance.
    Prior Authorization

    Imaging Prior Authorization — Delegation to Evolent and Specific Rules

    Many imaging services require prior authorization. Radiology prior authorization has been delegated to Evolent (NIA) for a broad set of radiology CPTs; certain ultrasounds and DXA/TBS rules and exceptions apply.

    • Prior authorization delegated to Evolent (NIA) for radiology services — follow Evolent routing where indicated.
    • OB ultrasound rules: first four OB ultrasounds do not require authorization; five or more for a normal pregnancy require authorization. OB ultrasounds for high-risk pregnancies do not require authorization.
    • DXA (77080/77081) — no authorization for specified age/diagnosis groups (women >65, men >70, and select age/diagnosis criteria for ages 51–69/51–64); other uses require authorization.
    • Therapy services (PT/OT/ST) after the initial evaluation require prior authorization through Evolent (NIA) for home/outpatient settings; home therapy initial evaluations require authorization and inpatient/home timing rules apply (see therapy callout).
    Prior Authorization

    Prior Authorization for Imaging/Therapeutic/Pain Management Services and Not Covered Low Back Pain Services

    Prior authorization is required for many imaging, therapeutic, and pain management services and for specific procedure codes. Some pain and therapeutic services are not covered for low back pain diagnoses.

    • Therapeutic services requiring authorization include phototherapy, hyperbaric oxygen, pain management injections and interventional pain codes (see list).
    • Pain management and interventional codes include 20526, 20550-20553, 21073, 27096, 62263-62327, 64400-64530, 64553-64595, 64600-64610, 64618-64640 and interventional codes 63650, 63655, 63661-63664, 63685, 63688, and related device HCPCS.
    • Not covered for members with diagnosis of Low Back Pain: prolotherapy; therapeutic facet joint steroid injections in lumbar/sacral regions (with or without CT guidance); therapeutic intradiscal steroid injections; continuous or intermittent traction.
    • Topical oxygen and specified other therapeutic services require prior authorization.
    Prior Authorization

    Oncology Medication and Appendix I Prior Authorization Routing

    Oncology medications and many drug administration/HCPCS (Appendix I) codes require prior authorization and have specific routing. Evolent manages oncology medication prior authorizations for most Medicaid/HARP members; Appendix I requests are routed to Fidelis Pharmacy.

    • Oncology medications and supportive agents — prior authorization required via Evolent (https://um.newcenturyhealth.com) for Medicaid Managed Care and HARP medical benefit (excludes Child Health Plus).
    • Appendix I lists HCPCS/CPT/J/Q/S/Q99x codes that require prior authorization; submit Appendix I prior authorization requests to Fidelis Pharmacy Team by e-fax 1-844-235-5090 unless excluded per section B.
    • Appendix I is distinct from the Evolent oncology program; certain oncology-related requests remain under Evolent — follow section-specific routing instructions.
    • HCPCS S codes are benefit exclusions except S0013, S0189, S0190, S0191, S9435; consult Appendix I and pharmacy guidance for S-code handling.
    Prior Authorization

    Appendix I — Codes Requiring Prior Authorization (Submission and Denial Risk)

    Appendix I enumerates numerous J-, Q-, C-, G-, J7xxx, Q5xxx, Q9xxx, and S-code groups that require prior authorization before billing. These codes must have prior authorization submitted and approved to avoid denial. Appendix I also contains codes that are non-covered when billed with specific diagnoses.

    • Appendix I is the authoritative list of medication and drug administration HCPCS/CPT codes that require PA prior to claim submission; examples include numerous J-codes (e.g., J0401, J0641…), Q-codes, C-codes, G0516/G0517, J7xxx series, and many oncology-related J9xxx/J92xx series.
    • Some Appendix I HCPCS for medications not FDA-approved (e.g., J1726) are benefit exclusions.
    • Certain HCPCS (e.g., J7318–J7333 series) are non-covered when billed with specific musculoskeletal diagnoses (see policy for code/diagnosis pairs).
    • Maximum unit edits apply to all HCPCS regardless of PA status; verify units against Fidelis Maximum Units policy.
    Documentation Required

    Documentation for Prior Authorization-Required Codes

    For services and codes that require prior authorization, ensure supporting documentation is submitted with the PA request and retain it for claims support. For Appendix I drug administration codes and other PA-required codes, include clinical indication, dosing/units, frequency, and relevant prior treatments.

    • Appendix I J- and Q- code administrations require PA submissions to Fidelis Pharmacy via e-fax 1-844-235-5090 unless routed to Evolent per oncology program guidance.
    • Include: clinical notes, diagnosis, prior therapy history, proposed dosing/units, expected duration, and site of administration.
    • Incomplete documentation or lack of PA may result in claim denial or retrospective medical necessity review.
    Prior Authorization

    Therapy Prior Authorization Timing and Routing

    Outpatient therapy prior authorization timing and routing: after the initial evaluation, outpatient/home therapy requires prior authorization through Evolent (NIA) with specific submission timeframes; inpatient therapy routing differs.

    • Home and outpatient PT/OT/ST (after the initial evaluation) require prior authorization through Evolent (NIA).
    • If submitting claims using codes other than designated initial evaluation CPT codes, an authorization request must be sent to Evolent (NIA) within 1 business day for outpatient settings or within 2 business days for the home health setting.
    • For therapy services provided in inpatient settings (POS 31 & 32), prior authorization requests are to be faxed to 833-663-1611.
    • CPT 92610 and 92611 (specified speech codes) do not require prior authorization.
    Documentation Required

    Home Health and Consumer-Directed Services — Authorization and Documentation

    Home health and consumer-directed services require authorization and documentation supporting skilled needs, and certain consumer-directed HCPCS/unit rules apply.

    • Home health approvals are based on documented medical need for skilled services.
    • Consumer Directed Personal Assistance (CDPAS) and Consumer Direct services require authorization and must be billed using the specified HCPCS (e.g., T1019U6–T1020U7) and unit conventions.
    • For Children's HCBS and respite exceeding program limits, submit LPHA attestation and NYS DOH forms (Children's HCBS Authorization and Care Manager Notification) prior to service delivery to avoid claim disruptions. Submit forms to SM_Childrens_HCBS@fideliscare.org or fax 833-663-1604.
    Documentation Required

    OMH and OASAS Notification and Documentation to Avoid Concurrent Review

    Providers must follow OMH and OASAS notification and documentation processes to avoid concurrent review during the initial inpatient periods and to ensure proper claims handling.

    • OMH licensed inpatient mental health (members <18): facility must notify Fidelis Care of admission and initial treatment plan within two business days using OMH 'Two-Day Notification and Initial Treatment Plan' form; submit by fax 833-561-0094 or email Mental_Health_Admission@fideliscare.org. No concurrent utilization review during first 14 days if requirements met.
    • OASAS licensed inpatient SUD: facility must notify Fidelis Care and submit OASAS Appendix A Notification Form and LOCADTR Medical Necessity Tool within two business days to fax 833-663-1608 or LOCADTR@fideliscare.org to avoid concurrent review for the first 28 days. Facilities must provide discharge plan prior to discharge and indicate whether services in the discharge plan are secured/available.
    • Facilities must perform daily clinical review and participate in periodic consultation with Fidelis starting near day 14 for SUD and day 14 for OMH to ensure appropriate use of clinical review criteria.
    Note

    Voicemail Compliance for UM Messages

    Utilization Management (UM) voicemail messages containing PHI may be left only if the provider voicemail is HIPAA-compliant. Mailbox greetings must identify owner and organization and state confidentiality and PHI acceptance.

    • If voicemail is HIPAA-compliant, UM will leave a detailed message. If not, a generic message requesting callback will be left.
    • When attempting UM determinations, Fidelis will make a second direct contact attempt per DOH Reasonable Effort Policy.

    Inpatient mental health admission criteria

    Inpatient mental health admission: In‑network OMH‑licensed hospitals: inpatient mental health treatment is not subject to prior authorization; for members under 18, no concurrent utilization review will be conducted during the first 14 days if the facility notifies Fidelis Care within two business days using the OMH Two‑Day Notification form, performs daily clinical review, and participates in periodic consultation. For all ages, utilization review is conducted only for members meeting OMH triggers (AOT, recent AOT, high utilization, 30‑day readmission) or when length of stay exceeds 30 days (concurrent review from Day 31 onward).14 days (under 18); concurrent review from Day 31 for extended stays

    Out‑of‑network facilities are subject to concurrent review throughout admission.

    partial hospitalization / intensive outpatient admission criteria

    partial hospitalization / intensive outpatient admission: Admission to Partial Hospitalization or Intensive Outpatient programs requires meeting NYS OMH Best Practice triggers (current or recent AOT order; high utilization in prior 12 months; readmission within 30 days) or the member will be subject to utilization review; length of stay exceeding 30 days triggers concurrent review from Day 31 onward. Intensive Outpatient requires no prior authorization for the first seven service days; additional days require authorization.First 7 days exempt for IOP; Day 31 for extended stays

    Out‑of‑network facilities subject to concurrent review throughout admission.

    Adult Day Health Care admission criteria

    Adult Day Health Care admission: Authorization is required for any new Adult Day Health Care (ADHC/AADHC) patient; prior authorization is also required for the initial assessment (up to two visits). Members enrolled as of 8/1/13 may remain for up to 90 days without a new authorization.New patients require authorization

    Continuation beyond transition period is reviewed for medical necessity.

    Out‑of‑network facilities are subject to concurrent review throughout admission.

    Adult Day Health Care continued stay criteria

    ADHC continued stay: Requests for continuation of Adult Day Health Care (ADHC/AADHC) services beyond the 90‑day transition period will be reviewed for medical necessity.Continuation requests reviewed

    Initial assessment up to two visits requires prior authorization for new patients.

    The first 7 service days for Intensive Outpatient Treatment and Mental Health Continuing Day Treatment do not require prior authorization; additional days require authorization.
    Codes / revenueApplies to revenue codes 905, 906, 912 and CPT 90899, HCPCS S9480, H2013 (intensive outpatient) and H2012 (continuing day treatment) per policy.
    Concurrent review triggersServices are subject to utilization review if members meet OMH clinical triggers (AOT orders, high utilization, readmission within 30 days) or length of stay exceeds 30 days.
    children's HCBS / respite annual limit
    Annual limit (children)Short‑term Planned and Crisis Respite for children is limited to 14 days (1,344 15‑minute units) per calendar year without medical necessity.
    Beyond limit documentationRespite beyond the annual limit requires LPHA attestation and NYS DOH Children's HCBS Authorization and Care Manager Notification form submitted to Fidelis Care prior to service.
    Claim avoidanceSubmit required forms before initial authorization expires and as soon as frequency, scope, and duration are determined to reduce claim processing delays.
    Home care / Consumer Directed — per diem day‑limit note
    Unit definitionConsumer Direct Live‑In services (T1020U6, T1020U7) are billed Per Diem — 1 unit per day.
    CDPAS codes and unitsConsumer Directed service HCPCS codes T1019U6, T1019U7, T1019U8, T1019U9 are billed per 15‑minute units; live‑in codes T1020U6/T1020U7 billed per diem.
    AuthorizationCDPAS and other consumer‑directed services require authorization per Home Health Care section.
    Submit the form by fax to 833‑561‑0094 (new) or by email to Mental_Health_Admission@fideliscare.org.
    Facility obligationsFacilities must perform daily clinical review and participate in periodic consultation with Fidelis Care when using the form to qualify for the 14‑day exemption.
    ABA eligibility and providers — definition
    EligibilityApplied Behavior Analysis (ABA) services are for members under age 21 diagnosed with autism spectrum disorder and/or Rett Syndrome per DSM‑5.
    Provider requirementsABA must be provided by Licensed Behavior Analysts (LBAs) or Certified Behavior Analyst Assistants (CBAAs) working under LBAs or other individuals specified under NYS Education Law, and enrolled in NYS Medicaid.
    AuthorizationPrior authorization is required from Behavioral Health; ABA authorization request form is available on the Fidelis Care provider forms page.
    Consumer Directed Personal Assistance Services (CDPAS) — definition and billing note
    DefinitionConsumer Directed Personal Assistance Services (CDPAS) are a Medicaid/Medicare benefit requiring authorization and billed using specified HCPCS codes with defined billing units.
    Billing unitsCDPAS HCPCS codes T1019U6/T1019U7/T1019U8/T1019U9 billed per 15 minutes; live‑in codes T1020U6/T1020U7 billed per diem (1 unit per day).
    Authorization noteCDPAS requires prior authorization per Home Health Care section; approvals are based on medical need for skilled services where applicable.
    DXA scans (77080/77081) — definition / authorization‑exception summary
    DefinitionDXA scans: CPT codes 77080 and 77081 are bone density studies with age‑ and diagnosis‑based authorization exceptions (one scan every two years for specified groups).
    No‑auth exceptions summaryAuthorization not required for: Women >65 and Men >70 (one 77080/77081 every 2 years with Z13.820); Women 51–64 and Men 51–69 (one 77080/77081 every 2 years with specified diagnosis codes).
    Other requestsRequests for 77080/77081 for other ages or diagnoses require prior authorization.
    One 77080 or 77081 every two years for eligible age/diagnosis groups; other uses require authorization.
    Short-term Planned and Crisis Respite — coding/frequency key value
    Unit and daysShort‑term Planned and Crisis Respite annual limit: 14 days per calendar year (equates to 1,344 15‑minute units).
    When additional PA neededServices beyond these limits require medical necessity documentation (LPHA attestation) and the NYS DOH Children's HCBS Authorization form submitted to Fidelis Care prior to service.
    Claim timing adviceSubmit forms before initial authorization expires and promptly when frequency, scope, and duration are determined to avoid claim delays.
    OB ultrasound allowance — coding/frequency key value
    Routine allowanceFirst 4 OB ultrasounds for a normal pregnancy may be performed without prior authorization; five or more require authorization.
    Relevant diagnosis codesExamples for normal pregnancy: Z32.01, Z33.1, Z34.00‑Z34.03, Z34.80‑Z34.83, Z34.9‑Z34.93.
    High‑risk exemptionOB ultrasounds for high‑risk pregnancy diagnosis codes (O09.xx, O36.80Xx, etc.) do not require authorization.
    DXA frequency — coding/frequency key value
    Allowed frequencyDXA (77080 or 77081): one test every two years for specified groups (Women >65, Men >70 with Z13.820; Women 51–64 and Men 51–69 with listed diagnosis codes).
    Other CPTsTBS scans (77089, 77090, 77091, 77092) are listed separately; authorization rules apply per policy.
    Authorization for othersAny 77080/77081 requests outside the specified age/diagnosis exceptions require prior authorization.
    DSMT units — coding/frequency key value
    Allowed unitsDSMT allowance: 10 hours (20 units) in a continuous 6‑month period.
    Billing codesDSMT services billed with G0108 and G0109.
    AuthorizationThese DSMT services no longer require prior authorization but must be provided by certified providers.